ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Morphological Predictors of Sudden Cardiac Death in Patients With Known Cardiomyopathies

This study is currently recruiting participants.
Study NCT00312624.   Last updated on June 3, 2008.   Information provided by University of Pittsburgh

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Morphological Predictors of Sudden Cardiac Death in Patients With Known Cardiomyopathies
Official Title  Morphological Predictors of Sudden Cardiac Death in Patients With Known Cardiomyopathies
Brief Summary

This is a pilot study to find a correlation between MRI and ICD therapy in patients with known cardiomyopathies, aiming to determine if cardiac scarring identified by MRI correlates with ventricular arrhythmias and the occurrence of ICD therapy.

Detailed Description

This is an observational study over a 3 year period of 50 patients with known cardiomyopathy and LVEF of 35% or less who will have ICD implantation as part of their standard of care. All subjects will undergo a contrast-enhanced cardiac MRI using gadolinium to determine the morphological characteristics of their left ventricle prior to ICD implant. Subjects will not be offered sedation to minimize risk, thus those suffering from claustrophobia will be excluded or dropped from participation. MRI will be evaluated, and subjects will be followed during standard of care device interrogations for 12 months after implant.

Study Phase
Study Type  Observational
Study Design  Cohort, Prospective
Primary Outcome Measure 
Secondary Outcome Measure 
Condition  Cardiomyopathy
Intervention  Procedure: contrast-enhanced cardiac MRI
MEDLINE PMIDs
Links
Recruitment Information Fields
Recruitment Status  Recruiting
Enrollment  50
Start Date  April 2006
Completion Date December 2008
Eligibility Criteria 

Inclusion Criteria:

  • at least 18 years of age
  • cardiomyopathy with LVEF 35% or less
  • indication for ICD implantation
  • able to provide informed consent

Exclusion Criteria:

  • prior device implantation
  • contraindication for MRI (i.e., metallic foreign body)
  • claustrophobia
  • pregnant women
Gender Both
Ages 18 Years and older
Accepts Healthy Volunteers Yes
Contacts ††
Contact: Samir Saba, MD     412-647-6272     sabas@upmc.edu    
Contact: Pamela M White, RN     412 647-2931     whitepm@upmc.edu    
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00312624
Organization ID 0602085
Secondary IDs †† 0602085
Study Sponsor  University of Pittsburgh
Collaborators ††
Investigators 
Principal Investigator:     Samir Saba, MD     University of Pittsburgh    
Information Provided By University of Pittsburgh
Verification Date June 2008
First Received Date  April 6, 2006
Last Updated Date June 3, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers